Aghemo A - Search Results

1

Assessing long-term treatment efficacy in chronic hepatitis B and C: between evidence and common sense.

Aghemo A, Lampertico P, Colombo M. Aghemo A, et al. J Hepatol. 2012 Dec;57(6):1326-35. doi: 10.1016/j.jhep.2012.06.025. Epub 2012 Jun 28. J Hepatol. 2012. PMID: 22750749 Free article. Review.

2

The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.

Monti V, Aghemo A, Rumi MG, Donato MF, Del Ninno E, Colombo M. Monti V, et al. Among authors: aghemo a. Antivir Ther. 2005;10(6):715-20. Antivir Ther. 2005. PMID: 16218170 Clinical Trial.

3

Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection.

Aghemo A, Rumi MG, Soffredini R, D'Ambrosio R, Ronchi G, Del Ninno E, Gallus S, Colombo M. Aghemo A, et al. Antivir Ther. 2006;11(6):797-802. Antivir Ther. 2006. PMID: 17310824

4

Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre study.

Rumi MG, Aghemo A, D'Ambrosio R, Ronchi G, Del Ninno E, Gallus S, Colombo M. Rumi MG, et al. Among authors: aghemo a. Antivir Ther. 2007;12(7):1033-40. Antivir Ther. 2007. PMID: 18018761

5

Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?

Aghemo A, Rumi MG, Colombo M. Aghemo A, et al. J Viral Hepat. 2008 Jun;15(6):471. doi: 10.1111/j.1365-2893.2008.00975.x. Epub 2008 Mar 6. J Viral Hepat. 2008. PMID: 18331249 No abstract available.

6

Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism.

Bersano A, Aghemo A, Rumi MG, Ballabio E, Candelise L, Colombo M. Bersano A, et al. Among authors: aghemo a. Eur J Intern Med. 2008 Jul;19(5):370-1. doi: 10.1016/j.ejim.2007.10.003. Epub 2007 Nov 28. Eur J Intern Med. 2008. PMID: 18549943

7

Cirrhosis regression in chronic hepatitis C: an old tale with a new ending.

Aghemo A, Colombo M. Aghemo A, et al. Gastroenterology. 2009 Mar;136(3):1114-6. doi: 10.1053/j.gastro.2009.01.033. Epub 2009 Jan 24. Gastroenterology. 2009. PMID: 19171147 No abstract available.

8

The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?

Aghemo A, Rumi MG, Prati GM, Colombo M. Aghemo A, et al. Hepatology. 2009 Feb;49(2):702-3; author reply 703-4. doi: 10.1002/hep.22732. Hepatology. 2009. PMID: 19177585 No abstract available.

9

Cirrhosis regression in chronic hepatitis C: an old tale with a new ending.

Aghemo A, Colombo M. Aghemo A, et al. Gastroenterology. 2009 Apr;136(4):1447-9. doi: 10.1053/j.gastro.2009.02.033. Epub 2009 Feb 25. Gastroenterology. 2009. PMID: 19250651 No abstract available.

10

High levels of factor VIII and risk of extra-hepatic portal vein obstruction.

Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell'Era A, Mannucci PM. Martinelli I, et al. Among authors: aghemo a. J Hepatol. 2009 May;50(5):916-22. doi: 10.1016/j.jhep.2008.12.020. Epub 2009 Feb 14. J Hepatol. 2009. PMID: 19304336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page